Talkiatry
PrivateLast Round
Series D
Feb 12, 2026
Total Funding Raised
$472M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Talkiatry is a mental health care company that provides in-network psychiatry and therapy services through a technology-enabled, human-centered platform.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, EHR & EMR
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Talkiatry Comparables
Compare Talkiatry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Octave | 86% | |
| Brightside Health | 85% | |
| Two Chairs | 85% |
For institutional investors. Book with your work email.
Talkiatry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Feb 12, 2026 | ||||
| Series C | Jun 18, 2024 | ||||
| Series B | Jul 1, 2022 | ||||
| Series A | Jan 27, 2022 | ||||
| Series A Extension | Jul 28, 2021 | ||||
Series A | Feb 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Talkiatry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series C |
| Perceptive Advisors | Series C, Series D |
| Gaingels | Series B |
| Park Ventures | Series A Extension |
| Left Lane Capital | Series D, Series C, Series B, Series A Extension, Series A |
| blisce/ | Series D, Series C, Series B |
| Sofina | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 41% MoM, reaching 3M.
- May 21, 2026
Delivered over two million patient visits nationwide.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 8, 2026
On Oct 8th '26, the American Medical Association recognizes Talkiatry as a Joy in Medicine(R) organization in New York for prioritizing methods that reduce physician burnout and enhance professional fulfillment.
For institutional investors. Book with your work email.
Talkiatry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Talkiatry's valuation, stock price, and market status.
Is Talkiatry a public or private company?
Talkiatry is a private company.
What is the current stock price of Talkiatry?
Talkiatry is a private company, so its shares have no public market price. Caplight tracks Talkiatry's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Talkiatry worth (valuation)?
Valuation information for Talkiatry is not publicly available.
Can I buy Talkiatry stock?
Talkiatry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Talkiatry's last funding round?
Talkiatry's most recent funding round was Series D on February 12, 2026.
Who are the main investors in Talkiatry?
Key investors in Talkiatry include Andreessen Horowitz, Perceptive Advisors, Left Lane Capital, blisce/.
Will Talkiatry IPO soon?
No public IPO plans have been announced for Talkiatry.
How can I track Talkiatry secondary market activity?
Caplight tracks bids, offers, and trades in Talkiatry's shares on secondary markets.